132 results
8-K
EX-99.2
AXGN
Axogen Inc.
2 May 24
Axogen, Inc Reports First Quarter 2024 Financial Results
7:00am
a te s
Outcomes from RANGER Registry 44,45 21 P IL L A R 3 Strong commitment to developing clinical evidence RANGER® Registry Study: Enrollment
S-8
EX-10.6
AXGN
Axogen Inc.
6 Mar 24
Registration of securities for employees
8:59am
share of the Company’s Common Stock and represents the Company’s commitment to issue one share of the Company’s Common Stock at a future date, subject … compensation otherwise payable to you by the Company; (ii) causing you to tender a cash payment; (iii) permitting you to enter into a “same day sale” commitment
S-8
EX-10.4
jghyjdrij mp4yek
6 Mar 24
Registration of securities for employees
8:59am
S-8
EX-10.7
lfds3y4
6 Mar 24
Registration of securities for employees
8:59am
S-8
EX-10.5
8j3 zimsl3n60jneruq
6 Mar 24
Registration of securities for employees
8:59am
8-K
EX-99.1
v8e9 nuoxrjefz5g75b
5 Mar 24
Regulation FD Disclosure
4:29pm
8-K
EX-99.1
lb8w2f4ygr5 op85m
8 Jan 24
Regulation FD Disclosure
7:05am
8-K
EX-99.1
oge 803dm
4 Jan 24
Results of Operations and Financial Condition
4:56pm
8-K
EX-99.2
1j34u6fz98op3fsq r2t
7 Nov 23
Axogen, Inc Reports 2023 Third Quarter Financial Results
7:13am
8-K
EX-99.2
ps2e 4cff7epos5gqnd
7 Aug 23
Axogen, Inc Reports 2023 Second Quarter Financial Results
4:08pm